CDNA
CareDx, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$85.35
−3.53%Next report
Analyst consensus
- Next report date
- Feb 23, 2027
- EPS estimate
- $0.36
- Revenue estimate
- $135.9M
Latest reported
- Last report date
- Oct 29, 2026
- EPS actual
- $0.70
- EPS estimate
- $0.25
- Revenue actual
- $139.4M
- Revenue estimate
- $122.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +77.4%
- Revenue beats (12Q)
- 8
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $86
- PT range
- $80 – $92
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 29, 2026 | $0.25 | $0.70 | Beat 174.73% | $139.4M |
| Jul 30, 2026 | $0.23 | $0.37 | Beat 59.41% | $131.9M |
| Apr 28, 2026 | $0.11 | $0.34 | Beat 209.09% | $117.7M |
| Feb 24, 2026 | $0.24 | -$0.08 | Miss -133.49% | $108.4M |
| Aug 6, 2025 | $0.12 | $0.10 | Miss -16.67% | $86.7M |
| Apr 30, 2025 | $0.06 | $0.09 | Beat 50.00% | $84.7M |
| Feb 26, 2025 | $0.05 | $0.18 | Beat 260.00% | $86.6M |
| Jul 31, 2024 | -$0.13 | $0.25 | Beat 292.31% | $92.3M |
| May 9, 2024 | -$0.19 | -$0.03 | Beat 84.21% | $72.0M |
| Feb 28, 2024 | -$0.24 | -$0.17 | Beat 29.17% | $65.6M |
| Feb 27, 2023 | -$0.06 | -$0.07 | Miss -16.67% | $82.4M |
| Nov 3, 2022 | -$0.14 | -$0.06 | Beat 57.14% | $79.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 23, 2027